logologo
QuantliQuantli

Prelude Therapeutics Inc

PRLD

NASDAQ

Biotechnology

$5.55

USD

+0.19 (+3.54%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $431.68M

Volume 452.1K

OverviewChartsFinancialsPeersFilings & NewsAnalyst RatingsTechnical Analysis

Peer Comparison Table

(1/4)

XFOR

X4 Pharmaceuticals Inc

$437.64M

-

-71.3%

-

ENTA

Enanta Pharmaceuticals Inc

$400.41M

-

+7.4%

-

CMPX

Compass Therapeutics Inc.

$399.80M

-

-

-

UPB

Upstream Bio Inc

$397.81M

-

+13.2%

-

RCKT

Rocket Pharmaceuticals Inc

$393.64M

-

-

-

PRLD

Prelude Therapeutics Inc

$384.69M

-

-

-

LXEO

Lexeo Therapeutics Inc

$363.56M

-

-

-

Top Peer by Growth

Prokidney Corp

+190.5% YoY Revenue

Lowest P/E Ratio

Q32 Bio Inc

15.71x P/E

Best 1-Year Return

Q32 Bio Inc

+749.2% Return